Recombinant Human Erythropoetin 4,000 Iu/Ml, Injectable Recombinant Human Erythropoetin 4,000 Iu/Ml, Injectable Glycosamine Sulfate 500 Mg + Chondroitin Sulfate 400 Mg Glycosamine Sulfate 500 Mg + Chondroitin Sulfate 400 Mg Rivastigmine 9Mg Transdermal Patch 4.6Mg/24H 5Cm2 Rivastigmine 9Mg Transdermal Patch 4.6Mg/24H 5Cm2 Valsartan 160Mg + Hydrochlorothiazide 12.5Mg Valsartan 160Mg + Hydrochlorothiazide 12.5Mg Rosuvastatin 40Mg Rosuvastatin 40Mg Rivastigmine 18Mg Transdermal Patch 9.5Mg/24H 10Cm2 Rivastigine 18Mg Transdermatic Patch 9.5Mg/24H 10Cm2 Cytidine 2.5Mg + Uridine 1.5Mg + Ocobalamin 1000Mcg Cytidine 2.5Mg + Uridine 1.5Mg + Hydroxocobalamin 1000Mcg Saxaglyptin 5Mg Saxagliptin 5Mg Sitagliptin 50Mg + Metformin 1000Mg Prolonged Release Sitagliptin 50Mg + Metformin 1000Mg Extended Release Nivolumab 10Mg/Ml Vial Containing 4Ml 40Mg Nivolumab 10Mg/Ml Vial Containing 4Ml 40Mg Insulin Glargine 300 U/Ml, In Disposable Pen 1.5 Ml Insulin Glargine 300 U/Ml, In Disposable Pen 1.5 Ml Insuli

Prefeitura Municipal de Jundiai Brazil has Released a tender for Recombinant Human Erythropoetin 4,000 Iu/Ml, Injectable Recombinant Human Erythropoetin 4,000 Iu/Ml, Injectable Glycosamine Sulfate 500 Mg + Chondroitin Sulfate 400 Mg Glycosamine Sulfate 500 Mg + Chondroitin Sulfate 400 Mg Rivastigmine 9Mg Transdermal Patch 4.6Mg/24H 5Cm2 Rivastigmine 9Mg Transdermal Patch 4.6Mg/24H 5Cm2 Valsartan 160Mg + Hydrochlorothiazide 12.5Mg Valsartan 160Mg + Hydrochlorothiazide 12.5Mg Rosuvastatin 40Mg Rosuvastatin 40Mg Rivastigmine 18Mg Transdermal Patch 9.5Mg/24H 10Cm2 Rivastigine 18Mg Transdermatic Patch 9.5Mg/24H 10Cm2 Cytidine 2.5Mg + Uridine 1.5Mg + Ocobalamin 1000Mcg Cytidine 2.5Mg + Uridine 1.5Mg + Hydroxocobalamin 1000Mcg Saxaglyptin 5Mg Saxagliptin 5Mg Sitagliptin 50Mg + Metformin 1000Mg Prolonged Release Sitagliptin 50Mg + Metformin 1000Mg Extended Release Nivolumab 10Mg/Ml Vial Containing 4Ml 40Mg Nivolumab 10Mg/Ml Vial Containing 4Ml 40Mg Insulin Glargine 300 U/Ml, In Disposable Pen 1.5 Ml Insulin Glargine 300 U/Ml, In Disposable Pen 1.5 Ml Insuli in Healthcare and Medicine. The tender was released on Aug 02, 2024.

Country - Brazil

Summary - Recombinant Human Erythropoetin 4,000 Iu/Ml, Injectable Recombinant Human Erythropoetin 4,000 Iu/Ml, Injectable Glycosamine Sulfate 500 Mg + Chondroitin Sulfate 400 Mg Glycosamine Sulfate 500 Mg + Chondroitin Sulfate 400 Mg Rivastigmine 9Mg Transdermal Patch 4.6Mg/24H 5Cm2 Rivastigmine 9Mg Transdermal Patch 4.6Mg/24H 5Cm2 Valsartan 160Mg + Hydrochlorothiazide 12.5Mg Valsartan 160Mg + Hydrochlorothiazide 12.5Mg Rosuvastatin 40Mg Rosuvastatin 40Mg Rivastigmine 18Mg Transdermal Patch 9.5Mg/24H 10Cm2 Rivastigine 18Mg Transdermatic Patch 9.5Mg/24H 10Cm2 Cytidine 2.5Mg + Uridine 1.5Mg + Ocobalamin 1000Mcg Cytidine 2.5Mg + Uridine 1.5Mg + Hydroxocobalamin 1000Mcg Saxaglyptin 5Mg Saxagliptin 5Mg Sitagliptin 50Mg + Metformin 1000Mg Prolonged Release Sitagliptin 50Mg + Metformin 1000Mg Extended Release Nivolumab 10Mg/Ml Vial Containing 4Ml 40Mg Nivolumab 10Mg/Ml Vial Containing 4Ml 40Mg Insulin Glargine 300 U/Ml, In Disposable Pen 1.5 Ml Insulin Glargine 300 U/Ml, In Disposable Pen 1.5 Ml Insuli

Deadline - login to view

MT reference number - 90033857

Product classification - Medical equipments, pharmaceuticals and personal care products